List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 117 studies with search of: "Niacin"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed A Placebo-Controlled Prospective Study to Evaluate Flushing in Subjects Administered Niaspan® Plus Aspirin for Six Weeks
Condition: Dyslipidemia
Interventions: Drug: Niaspan plus aspirin;   Drug: Niaspan plus aspirin placebo;   Drug: Niaspan placebo/aspirin placebo
2 Recruiting The Role of Dyslipidemia and Extended-Release Niacin in Stroke Recovery
Condition: Ischemic Stroke
Interventions: Drug: Extended-Release Niacin;   Drug: Extended-Release Niacin;   Drug: Placebo
3 Completed
Has Results 		A Study to Evaluate the Effects of Extended Release (ER) Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites in Subjects With High Cholesterol
Condition: Hypercholesterolemia
Interventions: Drug: Comparator: niacin + laropiprant;   Drug: Comparator: niacin;   Drug: Comparator: laropiprant;   Drug: Comparator: placebo
4 Completed Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2)(COMPLETED)
Conditions: Hypercholesterolemia;   Hyperlipidemia
Interventions: Drug: Vytorin + Niaspan;   Drug: Vytorin;   Drug: Niaspan
5 Recruiting Evaluation of the Effect of NICOtinic Acid (Niacin) on Elevated Lipoprotein(a) Levels (NICOLa Study)
Condition: Elevated Lipoprotein(a) Levels
Interventions: Drug: Nicotinic acid (niacin);   Drug: Placebo
6 Completed Study of the Abuse Liability of Oxycodone HCl/Niacin in Subjects With a History of Opioid Abuse
Condition: Opioid Abuse
Interventions: Drug: Niacin;   Drug: Oxycodone HCL plus Niacin;   Drug: Placebo;   Drug: Oxycodone HCL plus Niacin;   Drug: Oxycodone HCl
7 Completed To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia
Condition: Hypercholesterolemia
Interventions: Drug: Comparator: ezetimibe/simvastatin + niacin (ER);   Drug: Comparator: Placebo to ezetimibe/simvastatin;   Drug: Comparator: niacin (ER) tablet;   Drug: Comparator: ezetimibe (+) simvastatin;   Drug: Comparator: Placebo to Niacin (ER)
8 Completed
Has Results 		A Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Comparator: ER niacin (+) laropiprant;   Drug: Comparator: ER niacin;   Drug: Comparator: laropiprant;   Drug: Comparator: placebo
9 Active, not recruiting Exercise Versus Niacin in Patients With Coronary Artery Disease (CAD) and Low High-Density Lipoproteins (HDL)
Conditions: Coronary Disease;   Hypolipoproteinemia
Interventions: Behavioral: physical exercise;   Drug: niaspan (extended-release niacin);   Drug: niacin;   Other: control
10 Active, not recruiting Niacin, N-3 Fatty Acids and Insulin Resistance
Conditions: Metabolic Syndrome;   Hypertriglyceridemia
Interventions: Drug: omega-3 acid ethyl esters;   Drug: extended release niacin;   Drug: placebo;   Drug: omega-3 acid ethyl esters;   Drug: combined treatment
11 Completed SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia
Condition: Dyslipidemia
Intervention: Drug: Slo-Niacin, atorvastatin
12 Recruiting Niacin and Endothelial Function in Early CKD
Condition: Chronic Kidney Disease
Interventions: Drug: Niacin;   Drug: Active Placebo
13 Completed Extended Niacin/Laropiprant in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus Type 2
Interventions: Drug: ER niacin/laropiprant;   Drug: Comparator : placebo (unspecified)
14 Active, not recruiting Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)
Condition: Peripheral Arterial Disease
Interventions: Drug: Ezetimibe;   Drug: Niaspan;   Drug: Statin therapy;   Behavioral: Standard care;   Drug: Aspirin;   Drug: Clopidogrel;   Drug: Placebo Niaspan;   Drug: Placebo Ezetimibe;   Procedure: Percutaneous transluminal angioplasty (PTA)
15 Completed A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers
Condition: Healthy Subjects
Intervention: Drug: GSK256073A tablets + IR niacin tablets
16 Completed Study to Evaluate the EFFECTS of Acetylsalicylic Acid on Niaspan®-Induced Flushing in Subjects With Dyslipidemia
Condition: Dyslipidemia
Interventions: Drug: ABT-919;   Drug: ASA;   Drug: niacin placebo;   Drug: ASA placebo
17 Active, not recruiting Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions
Conditions: Central Retinal Vein Occlusion;   Branch Retinal Vein Occlusion
Intervention: Drug: nicotinic acid
18 Recruiting Niacin As Secondary Prevention Of Coronary Artery Disease (NASPOCAD)
Condition: Coronary Artery Disease
Interventions: Drug: Niacin;   Drug: Niacin+Statin
19 Completed Tolerability of MK0524A Versus Niacin Extended-Release
Conditions: Hypercholesterolemia;   Hyperlipidemia
Interventions: Drug: niacin (+) laropiprant;   Drug: niacin
20 Completed Effect of an Investigational Compound on Tolerability of Extended Release Niacin
Conditions: Hypercholesteremia;   Hyperlipidemia
Interventions: Drug: niacin (+) laropiprant;   Drug: Comparator : niacin

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services